سعر تارج 160مجم 14 قرص 2024

Valsartan 160 mg film-coated tablets, pack of 14, by Novartis; angiotensin II receptor blocker for hypertension.

• Hypertension, to lower blood pressure, in adults and paediatric patients 1 year and older.Population: Adults and children >=1 yearDailyMed (U.S. National Library of Medicine)
• Heart failure (NYHA class II-IV) to reduce the risk of hospitalisation.Population: AdultsDailyMed (U.S. National Library of Medicine)
• Post-myocardial infarction in clinically stable patients with left ventricular failure or dysfunction, to reduce cardiovascular mortality.Population: AdultsDailyMed (U.S. National Library of Medicine)

• Hypertension trials: viral infection (3%), fatigue (2%) and abdominal pain (2%) more often than placebo; headache and dizziness were the main reasons for discontinuation.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Known hypersensitivity to any component.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Do not coadminister aliskiren in patients with diabetes.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Boxed warning - fetal toxicity: discontinue as soon as pregnancy is detected.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Hypotension in volume- or salt-depleted patients; impaired renal function including acute renal failure; hyperkalaemia.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Potassium-sparing diuretics, potassium supplements, salt substitutes, heparinMay increase serum potassium; monitor potassium.DailyMed (U.S. National Library of Medicine)
• NSAIDs including COX-2 inhibitorsRisk of renal deterioration in elderly, volume-depleted or renally impaired patients; may attenuate the antihypertensive effect.DailyMed (U.S. National Library of Medicine)
• ACE inhibitors, other ARBs, aliskiren (dual RAS blockade)Increased risk of hypotension, hyperkalaemia and renal impairment; generally avoid; aliskiren contraindicated in diabetes and to be avoided if GFR <60 mL/min.DailyMed (U.S. National Library of Medicine)

• Can cause fetal harm; drugs acting on the renin-angiotensin system in the second and third trimesters reduce fetal renal function and increase fetal and neonatal morbidity and death. Discontinue when pregnancy is detected.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• No human data; present in rat milk; breastfeeding not recommended during treatment.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Valsartan: Blocks vasoconstrictor and aldosterone-secreting effects of angiotensin II at the AT1 receptor.